92 related articles for article (PubMed ID: 9274458)
1. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
[No Abstract] [Full Text] [Related]
2. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
4. [Changes in chemotherapy for pancreatic adenocarcinoma].
Hammel P
Gastroenterol Clin Biol; 2002; 26(6-7):603-4. PubMed ID: 12193859
[No Abstract] [Full Text] [Related]
5. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
[TBL] [Abstract][Full Text] [Related]
6. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study.
Louvet C; Beerblock K; de Gramont A; Varette C; Demuynck B; Bennamoun M; Cady J; Delfau S; Maisani JE; Krulik M
Eur J Cancer; 1993; 29A(8):1217. PubMed ID: 8518038
[No Abstract] [Full Text] [Related]
7. A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients.
Vokes EE; Ratain MJ; Janisch L; Hoffman PC; Golomb HM; Schilsky RL
Eur J Cancer; 1991; 27(2):217-8. PubMed ID: 1827293
[No Abstract] [Full Text] [Related]
8. [Chemotherapy in adenocarcinomas of the pancreas].
Huguier M
Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
[No Abstract] [Full Text] [Related]
9. Advanced pancreatic cancer--5 years on.
Rao S; Cunningham D
Ann Oncol; 2002 Aug; 13(8):1165-8. PubMed ID: 12181237
[No Abstract] [Full Text] [Related]
10. Chemotherapy in advanced pancreatic adenocarcinoma.
Kollmannsberger C; Peters HD; Fink U
Cancer Treat Rev; 1998 Apr; 24(2):133-56. PubMed ID: 9728423
[No Abstract] [Full Text] [Related]
11. FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer.
González-Barón M; Feliu J; Espinosa E; García-Girón C; Chacon I; Garrido P; Colmenarejo A
Eur J Cancer; 1994; 30A(11):1733-4. PubMed ID: 7833158
[No Abstract] [Full Text] [Related]
12. cis-platinum, 5-fluorouracil, and hydroxyurea in the treatment of advanced non-small-cell lung cancer. A phase II study.
Axelson JA; Clark RH; Dimitrov NV
Am J Clin Oncol; 1987 Jun; 10(3):243-4. PubMed ID: 3035912
[TBL] [Abstract][Full Text] [Related]
13. Preliminary report of high dose folinic acid and 5-fluorouracil alone or combined with hydroxyurea in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research.
Di Costanzo F; Malacarne P; Zironi S; Marzola M; Cornia E; Figoli F; Bacchi M; Passalacqua R; Algeri R; Bartolucci R
J Surg Oncol Suppl; 1991; 2():137-40. PubMed ID: 1892522
[No Abstract] [Full Text] [Related]
14. Complete pathologic responses to preoperative chemoradiation in two patients with adenocarcinoma of the pancreas.
Magnin V; Viret F; Moutardier V; Lelong B; Giovannini M; Monges G; Delpero JR
Pancreas; 2004 Jan; 28(1):103-4. PubMed ID: 14707739
[No Abstract] [Full Text] [Related]
15. [Effect of preoperative FPL (5-fluorouracil, cisplatin, leucovorin) therapy on patients with primary unresectable advanced gastric cancer].
Tsujinaka T; Kato T; Shiozaki H; Murata A; Nishijima J; Kobayashi K; Inoue M; Miyata M; Kido Y; Mori T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):303-6. PubMed ID: 8434971
[No Abstract] [Full Text] [Related]
16. Response of pancreatic carcinoma to 5-fluorouracil and leucovorin.
Grinblatt DL; Benson AB
Am J Med; 1992 Jan; 92(1):107-9. PubMed ID: 1731500
[No Abstract] [Full Text] [Related]
17. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.
André T; Balosso J; Louvet C; Hannoun L; Houry S; Huguier M; Colonna M; Lotz JP; De Gramont A; Bellaïche A; Parc R; Touboul E; Izrael V
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):903-11. PubMed ID: 10705012
[TBL] [Abstract][Full Text] [Related]
18. [5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].
Taïeb J; Lecomte T; Ezenfis J; Artru P; Mitry E; Boige V; Clavero-Fabri MC; Vaillant JN; Rougier P; Ducreux M
Gastroenterol Clin Biol; 2002; 26(6-7):605-9. PubMed ID: 12193860
[TBL] [Abstract][Full Text] [Related]
19. 5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study.
Nose H; Okada S; Okusaka T; Furuse J; Yoshino M; Ogoshi K; Kato T; Miyaji M; Hoshino M; Ariyama J; Suyama M; Karasawa E; Yoshimori M
Hepatogastroenterology; 1999; 46(30):3244-8. PubMed ID: 10626195
[TBL] [Abstract][Full Text] [Related]
20. Dual modulation of 5-fluorouracil with folinic acid and hydroxyurea in metastatic colorectal cancer.
de Gramont A; Louvet C; Bennamoun M; Varette C; Demuynck B; Beerblock K; Moreau S; Soubrane D; Mal F; Grangé JD; Zylberait D; Krulik M
J Infus Chemother; 1996; 6(2):97-101. PubMed ID: 8809658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
